Avalyn Pharma Inc. (AVLN) KPIs and segments
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)
Close on Nov 17, 2026Market cap $1.24BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Avalyn Pharma's business
Coming soon
This tab will track the numbers specific to Avalyn Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?